- Forums
- ASX - By Stock
- MSB
- Ann: FDA Grants Orphan Drug Designation for Revascor
Ann: FDA Grants Orphan Drug Designation for Revascor, page-3
-
- There are more pages in this discussion • 270 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.05 |
Change
-0.020(1.88%) |
Mkt cap ! $1.187B |
Open | High | Low | Value | Volume |
$1.07 | $1.07 | $1.04 | $1.953M | 1.856M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 51595 | $1.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.05 | 115795 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 51495 | 1.045 |
24 | 221020 | 1.040 |
22 | 151377 | 1.035 |
27 | 275670 | 1.030 |
16 | 249650 | 1.025 |
Price($) | Vol. | No. |
---|---|---|
1.050 | 115795 | 15 |
1.055 | 55441 | 11 |
1.060 | 179227 | 14 |
1.065 | 175494 | 10 |
1.070 | 20700 | 2 |
Last trade - 11.25am 21/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online